Search

Author/Creator Vellemans, H.

1. P699: REAL-LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5-YEAR-DATA FROM A BELGIAN REGISTRY. (23rd June 2022)

Authors:
Devos, T.; Havelange, V.; Theunissen, K.; Meers, S.; Benghiat, F. S.; Gadisseur, A.; Vanstraelen, G.; Vellemans, H.; Bailly, B.; Granacher, N.; Lewalle, P.; De Becker, A.; Van Eygen, K.; Lejeune, M.; Janssen, M.; Triffet, A.; Vrelust, I.; Deeren, D.; Mazure, D.; Beck, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
594
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION. (12th June 2019)

Authors:
Cazelles, C.; Belhadj, K.; Vellemans, H.; Camus, V.; Copi‐Bergman, C.; Veresezan, L.; Itti, E.; Becker, S.; Carvalho, M.; Dupuis, J.; Fabien, L.; Lemonnier, F.; Roulin, L.; El Gnaoui, T.; Jardin, F.; Mounier, N.; Tilly, H.; Haioun, C.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
429
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search